Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,669 Cr₹1,541 Cr₹1,242 Cr₹1,107 Cr₹968 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,669 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,669 Cr
Mar2023₹1,541 Cr
Mar2022₹1,242 Cr
Mar2021₹1,107 Cr
Mar2020₹968 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2024 ₹1,669 Cr
8.30
Mar2023 ₹1,541 Cr
24.10
Mar2022 ₹1,242 Cr
12.19
Mar2021 ₹1,107 Cr
14.26
Mar2020 ₹968 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,984.1 Cr -3.8% -3.3% -14% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-3.8%

-3.3%

-14%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses